Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Kidney Failure, Chronic | HyperphosphatemiaDuring end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due to heart disease, improve physical health, and be cost-effective.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
1. Age ≥45 years, or Age ≥18 years with diabetes,
2. ESKD on haemodialysis or peritoneal dialysis, for at least 3 months,
3. Currently prescribed at least one phosphate-lowering medication at any dose
4. Able to provide informed consent
Exclusion Criteria:
1. Elective kidney transplantation scheduled,
2. Concomitant major illness / comorbidity that may result in death in the next 6 months in the view of the treating physician,
3. Participation in an interventional study that is likely to affect serum phosphate concentration.
Lieu de l'étude
Foothills Hospital/ U of Calgary
Foothills Hospital/ U of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
Dalhousie University
Dalhousie UniversityHalifax, Nova Scotia
Canada
Contactez l'équipe d'étude
Orillia Soldier's Memorial Hospital
Orillia Soldier's Memorial HospitalOrillia, Ontario
Canada
Contactez l'équipe d'étude
Daniel Tascona, Dr
St Michael's Hospital
St Michael's HospitalToronto, Ontario
Canada
Contactez l'équipe d'étude
The Charles Lemoyne Hospital
The Charles Lemoyne HospitalLongueuil, Quebec
Canada
Contactez l'équipe d'étude
Dominic Poirier, Dr
Jewish General Hospital
Jewish General HospitalMontréal, Quebec
Canada
Contactez l'équipe d'étude
Vancouver General Hospital
Vancouver General HospitalVancouver, British Columbia
Canada
Contactez l'équipe d'étude
Claire Harris, Dr
Oakville Trafalgar Memorial Hospital
Oakville Trafalgar Memorial HospitalOakville, Ontario
Canada
Contactez l'équipe d'étude
Scarborough Hospital Network
Scarborough Hospital NetworkScarborough, Ontario
Canada
Contactez l'équipe d'étude
St. Joseph's Healthcare Toronto
St. Joseph's Healthcare TorontoToronto, Ontario
Canada
Contactez l'équipe d'étude
CHUM
CHUMMontréal, Quebec
Canada
Contactez l'équipe d'étude
Centre Hospitalier Universitaire de Sherbrooke
Centre Hospitalier Universitaire de SherbrookeSherbrooke, Quebec
Canada
Contactez l'équipe d'étude
Martin Plaisance, Dr
Alberta Health Services
Alberta Health ServicesEdmonton, Alberta
Canada
Contactez l'équipe d'étude
David Collister
Queen's University
Queen's UniversityKingston, Ontario
Canada
Contactez l'équipe d'étude
Lakeridge Health
Lakeridge HealthOshawa, Ontario
Canada
Contactez l'équipe d'étude
University Health Network - University of Toronto
University Health Network - University of TorontoToronto, Ontario
Canada
Contactez l'équipe d'étude
McGill University Health Centre
McGill University Health CentreMontreal, Quebec
Canada
Contactez l'équipe d'étude
Sacre Coeur Hospital
Sacre Coeur HospitalMontréal, Quebec
Canada
Contactez l'équipe d'étude
St. Paul's Hospital
St. Paul's HospitalVancouver, British Columbia
Canada
Contactez l'équipe d'étude
London Health Sciences Centre
London Health Sciences CentreLondon, Ontario
Canada
Contactez l'équipe d'étude
The Ottawa Hospital
The Ottawa HospitalOttawa, Ontario
Canada
Contactez l'équipe d'étude
St. Joseph's Healthcare Hamilton
St. Joseph's Healthcare HamiltonToronto, Ontario
Canada
Contactez l'équipe d'étude
Hopital Maisonneuve Rosemont
Hopital Maisonneuve RosemontMontréal, Quebec
Canada
Contactez l'équipe d'étude
CHU de Quebec Universite Laval
CHU de Quebec Universite LavalQuebec City, Quebec
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- The University of Queensland
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT03573089